The Beauty Health Company Statistics
Total Valuation
SKIN has a market cap or net worth of $276.48 million. The enterprise value is $443.21 million.
Important Dates
The last earnings date was Thursday, August 7, 2025, after market close.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SKIN has 126.83 million shares outstanding. The number of shares has decreased by -1.73% in one year.
| Current Share Class | 126.83M |
| Shares Outstanding | 126.83M |
| Shares Change (YoY) | -1.73% |
| Shares Change (QoQ) | +12.16% |
| Owned by Insiders (%) | 9.39% |
| Owned by Institutions (%) | 59.04% |
| Float | 81.55M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 28.21 |
| PS Ratio | 0.88 |
| Forward PS | 0.86 |
| PB Ratio | 3.73 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 7.05 |
| P/OCF Ratio | 7.01 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.43 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 11.30 |
Financial Position
The company has a current ratio of 5.15, with a Debt / Equity ratio of 5.09.
| Current Ratio | 5.15 |
| Quick Ratio | 3.99 |
| Debt / Equity | 5.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | 9.61 |
| Interest Coverage | -3.75 |
Financial Efficiency
Return on equity (ROE) is -26.54% and return on invested capital (ROIC) is -4.99%.
| Return on Equity (ROE) | -26.54% |
| Return on Assets (ROA) | -4.45% |
| Return on Invested Capital (ROIC) | -4.99% |
| Return on Capital Employed (ROCE) | -9.68% |
| Revenue Per Employee | $403,204 |
| Profits Per Employee | -$24,714 |
| Employee Count | 769 |
| Asset Turnover | 0.51 |
| Inventory Turnover | 1.75 |
Taxes
In the past 12 months, SKIN has paid $459,000 in taxes.
| Income Tax | 459,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +68.99% in the last 52 weeks. The beta is 1.20, so SKIN's price volatility has been higher than the market average.
| Beta (5Y) | 1.20 |
| 52-Week Price Change | +68.99% |
| 50-Day Moving Average | 1.82 |
| 200-Day Moving Average | 1.56 |
| Relative Strength Index (RSI) | 60.82 |
| Average Volume (20 Days) | 1,496,146 |
Short Selling Information
The latest short interest is 12.54 million, so 9.89% of the outstanding shares have been sold short.
| Short Interest | 12.54M |
| Short Previous Month | 12.36M |
| Short % of Shares Out | 9.89% |
| Short % of Float | 15.38% |
| Short Ratio (days to cover) | 16.45 |
Income Statement
In the last 12 months, SKIN had revenue of $310.06 million and -$19.01 million in losses. Loss per share was -$0.22.
| Revenue | 310.06M |
| Gross Profit | 190.69M |
| Operating Income | -43.40M |
| Pretax Income | -80.63M |
| Net Income | -19.01M |
| EBITDA | -15.72M |
| EBIT | -43.40M |
| Loss Per Share | -$0.22 |
Full Income StatementBalance Sheet
The company has $210.00 million in cash and $376.73 million in debt, giving a net cash position of -$166.73 million or -$1.31 per share.
| Cash & Cash Equivalents | 210.00M |
| Total Debt | 376.73M |
| Net Cash | -166.73M |
| Net Cash Per Share | -$1.31 |
| Equity (Book Value) | 74.00M |
| Book Value Per Share | 0.58 |
| Working Capital | 246.67M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $39.43 million and capital expenditures -$215,000, giving a free cash flow of $39.21 million.
| Operating Cash Flow | 39.43M |
| Capital Expenditures | -215,000 |
| Free Cash Flow | 39.21M |
| FCF Per Share | $0.31 |
Full Cash Flow StatementMargins
Gross margin is 61.50%, with operating and profit margins of -14.00% and -6.13%.
| Gross Margin | 61.50% |
| Operating Margin | -14.00% |
| Pretax Margin | -5.98% |
| Profit Margin | -6.13% |
| EBITDA Margin | -5.07% |
| EBIT Margin | -14.00% |
| FCF Margin | 12.65% |
Dividends & Yields
SKIN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.73% |
| Shareholder Yield | 1.73% |
| Earnings Yield | -6.87% |
| FCF Yield | 14.18% |
Analyst Forecast
The average price target for SKIN is $1.13, which is -48.17% lower than the current price. The consensus rating is "Sell".
| Price Target | $1.13 |
| Price Target Difference | -48.17% |
| Analyst Consensus | Sell |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 2.52% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SKIN has an Altman Z-Score of -0.2 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.2 |
| Piotroski F-Score | 5 |